Letters, Testimony & Filings Presentation at the FDA’s Public Hearing Entitled “Standards for Future Opioid Analgesic Approvals and Incentives for New Therapeutics to Treat Pain and Addiction” September 17, 2019
Press Releases FDA’s Double Denial Concerning Its Delinquency in Urgently Implementing Better Opioid Regulation September 9, 2019
Viewpoint Article Published in JAMA Internal Medicine: The Public Health Urgency of a Temporary FDA Moratorium on New Opioid Approvals September 3, 2019
Comments on the FDA’s Draft Guidance for Industry Entitled “Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework” August 20, 2019
Fact Sheets & Backgrounders New Study Finds Pharmaceutical Marketing of Opioid Products to Doctors is Linked to Increased Opioid-Related Deaths May 1, 2019
Press Releases Press Release: Responses of Dr. Sidney Wolfe, Founder and Senior Adviser, Public Citizen’s Health Research Group, to Gottlieb Testimony on Opioids March 29, 2019